Last year, the drivers behind startup SinfoniaRx announced the launch of UAVenture Capital to support commercialization at the UA. Now, they are announcing a second fund targeting $100 million to further the advance of UA innovations.

Through TLA, the University of Arizona is partnering with Kerafast to license reagents that offer the opportunity for the development of a rapid, highly sensitive diagnostic test for Cryptosporidiosis, the leading cause of waterborne diseases among people in the U.S.

Researchers at the University of Arizona have discovered a protein that prevents mosquitoes from hatching, opening the possibility of developing new drugs that could act as birth control for mosquito populations.

Dr. Thomas Koch and Dr. Harrison Barrett are being honored as National Academy of Inventors Fellows, which is the highest professional distinction awarded to academic inventors.

Download the FY2018 Annual Report and review our progress against our vision and goals, and learn more about how the culture of commercialization is growing throughout the University of Arizona ecosystem.

At the 2018 Governor’s Celebration of Innovation in Phoenix, this year’s finalists included three impactful University of Arizona-associated companies and inventors, two of which went on to be selected as winners.